Beyond One-Size-Fits-All: How Doctors, Nurses, and Pharmacists Drive True Health Equity?

To bridge global health disparities, the clinical triad—doctors, nurses, and pharmacists—must look beyond the baseline of identical treatment and champion individualized care.

Published in Sustainability and Public Health

Beyond One-Size-Fits-All: How Doctors, Nurses, and Pharmacists Drive True Health Equity?
Like

Share this post

Choose a social network to share with, or copy the URL to share elsewhere

This is a representation of how your post may appear on social media. The actual post will vary between social networks

Applying a single, rigid standard of care ignores the social determinants of health (SDoH). It overlooks systemic discrimination, language barriers, and socioeconomic status. It treats the symptoms of a disease while blinding clinicians to the context of the individual.
To achieve The United Nations Sustainable Development Goal 3 (SDG 3): Good Health and Well-Being, healthcare must pivot and shift our paradigm from “generic equality to tailored equity”.
True health equity demands that the clinical triad—doctors, pharmacists, and nurses— bring healthcare workers out of their separate departments to solve problems together. Here is how research from BMC and Springer illustrates how this can be achieved.




Doctors: Promoting Inclusivity and Affirming Context

Recent evidence suggests that this identity-blind approach compromises patient safety particularly for marginalized groups. When a doctor ignores a patient's unique societal stressors, those stressors go untreated.
A  study in  BMC Public Health  demonstrates that standardized clinical approaches often fail to address the intersection of discrimination and specialized medical vulnerabilities. The research details how standardized, "one-size-fits-all" clinical approaches cause healthcare providers to, often, overlook specific stressors related to minority group individuals. To achieve true equity and align with SDG 3, clinicians must adopt identity-sensitive pathways that recognize the physical toll of chronic stigma and environmental factors and further highlight the danger of this dynamic. 




Nurses: The Frontline Equity Advocates

Nurses spend the most time at the patient’s bedside. They are the first to witness the subtle nuances of patient discomfort, systemic neglect, or a breakdown in communication. Because of this frontline positioning, nurses are a patient's primary equity advocate. However, an advocate can only be effective if the medical hierarchy allows their voice to be heard. Patient equity is fundamentally tied to how clinical power is balanced within a healthcare team.

A study involving over 3,600 healthcare professionals published in BMC Medical Education shed light on this exact systemic challenge. The researchers tracked the willingness of various healthcare professionals to share clinical responsibilities and decision-making authority. The findings revealed that while allied health workers and nurses are highly motivated to share responsibility to optimize patient safety, rigid medical hierarchies and professional barriers still stand in the way.
To achieve the systemic health improvements outlined in SDG 3, healthcare frameworks must embrace shared responsibility. When doctors actively decentralize authority and elevate the voices of nursing staff, the team can pivot swiftly to meet the individualized, non-standardized needs of a struggling patient.




Pharmacists: Ensuring Fairness and Bridging Literacy Gaps

Health equity is entirely unachievable if life-saving medications never properly reach the communities that need them most. Pharmacists are often viewed merely as dispensers of medicine, but they hold immense, underutilized power as structural equalizers in primary care. Equal treatment at the pharmacy counter means dispensing the same pill with the same English instructions; equitable treatment means ensuring the patient actually understands and can manage their therapy safely.
A recent study published in BMC- International Journal for Equity in Health provides a blueprint for this proactive approach. The research evaluated interprofessional healthcare models where pharmacists stepped out from behind the counter to lead culturally adapted medication adherence programs and chronic disease screenings within underserved communities.
The study demonstrated that when pharmacists purposefully bridge cultural and linguistic gaps—frequently partnering with local community leaders to deliver health literacy in a patient's native language—they directly erase deeply entrenched health disparities. By transforming the pharmacy into an active point-of-care equity hub, pharmacists ensure that structural barriers like low health literacy or systemic distrust do not prevent vulnerable populations from achieving the health outcomes promised by SDG 3.




Conclusion: Activating the Triad 

* Doctors can validate and treat the patient's unique social context, not just their physical symptoms.
* Nurses can be structurally empowered to exercise shared clinical authority on behalf of patient safety.
* Pharmacists can proactively dismantle cultural and linguistic barriers to medication access.




References: 
1. BMC Public Health (https://link.springer.com/article/10.1186/s12889-023-16443-8)
2. BMC Medical Education (https://link.springer.com/article/10.1186/s12909-024-06351-9) 3. International Journal for Equity in Health (https://link.springer.com/article/10.1186/s12939-025-02377-7)

Please sign in or register for FREE

If you are a registered user on Research Communities by Springer Nature, please sign in

Follow the Topic

Public Health
Life Sciences > Health Sciences > Public Health
SDG 3: Good Health & Wellbeing
Research Communities > Community > Sustainability > UN Sustainable Development Goals (SDG) > SDG 3: Good Health & Wellbeing

Related Collections

With Collections, you can get published faster and increase your visibility.

Monitoring, preventing, and managing type 2 diabetes

BMC Public Health is calling for submissions to our Collection on Monitoring, preventing, and managing diabetes at the population level. With rates of type 2 diabetes rising globally, especially in low- and middle-income countries and underserved communities, prevention strategies are critical. As the disease progresses people with diabetes are at increased risk of complications such as cardiovascular and kidney diseases, neuropathy and visual loss.

This Collection seeks submissions that explore population-level approaches to monitoring rates of diabetes, preventing or delaying the development of type 2 diabetes, and system-wide efforts to improve the management of the disease and reduce rates of complications, with a focus on improving health outcomes and reducing healthcare burdens.

Submissions are encouraged on primary prevention initiatives and culturally adapted, community-level interventions to reduce the risk of diabetes. Research aimed at improving systems for monitoring rates of diabetes and its complications through routinely-collected health data, or for improving management by enhancing patient engagement with healthcare systems or better identifying those in need, are encouraged. Research on diabetes education and support systems is also welcomed, with a focus on empowering individuals to adopt and sustain healthier lifestyles and avoid known causes of diabetes.

Additional topics of interest include (but are not limited to):

Access to healthcare and diabetes management

The impact of food insecurity on diabetes outcomes

Community-based interventions for low-income populations

Interventions to reduce exposure to environmental causes of diabetes

Financial barriers to diabetes medication and treatment

Housing instability, employment status and type 2 diabetes

Health literacy, poverty, and diabetes management

Policies to reduce poverty-related health disparities in diabetes

This Collection supports and amplifies research related to SDG 3: Good Health & Well-Being.

All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.

Publishing Model: Open Access

Deadline: Jul 16, 2026

Endocrine disruption as a public health issue

BMC Public Health invites submissions to our new Collection, Endocrine disruption as a public health issue. Endocrine disruption has emerged as a growing public health challenge, characterized by the interference of certain chemicals with the normal functioning of the endocrine system. Endocrine disrupting chemicals (EDCs) can mimic, block, or alter hormone signaling, leading to a range of adverse health outcomes. Common sources of EDC exposure include everyday products such as plastics, pesticides, and personal care items, all of which can release substances like bisphenols and phthalates into the environment and human body. Understanding the links between exposure to EDCs and eventual health outcomes is vital for assessing their implications for population health.

We welcome submissions that delve into various aspects of endocrine disruption. Key topics of interest include, but are not limited to:

Role of EDCs in metabolic, endocrine and immune-related disorders

Effect of EDCs in consumer products including personal care products

The links between EDC exposure and male and female reproductive health problems

The links between EDC exposure and certain cancers

Insights into the long-term consequences of early-life EDC exposure and transgenerational effects

Methodological advances in assessing the health impacts of EDC mixtures and cumulative exposures

Development and application of statistical approaches to better estimate the health effects of chronic and/or concurrent exposure

Validating models of cumulative exposure with measurement of combinations of EDCs in human tissues

Individual- and policy-level interventions to address health impacts of EDC exposures

The search for substitutes lacking endocrine disrupting properties

All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.

Publishing Model: Open Access

Deadline: Aug 26, 2026